CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model (IMRCC), in patients (pt) treated with pazopanib (Pz) as first line for metastatic renal carcinoma (mRC): First results of the SOGUG SPAZO study.
Author
Alvaro Pinto
Angel Rodriguez Sanchez
+18 more
Aranzazu Gonzalez del Alba
Begoña Perez-Valderrama
Constanza Maximiano Alonso
Daniel E. Castellano
Edelmira Velez De Mendizabal
Gustavo Rubio
Isabel Chirivella
Javier L. Puertas
Jose Angel Arranz Arija
Jose-Luis Gonzalez-Larriba
José Carlos Villa Guzman
Julio Jose Lambea- Sorrosal
Luis León Mateos
Martin Lázaro Quintela
María José Juan Fita
Pablo Borrega
Raquel Luque
Rocio García Domínguez
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref